Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China · Delayed Price · Currency is CNY 56.44
-1.81 (-3.11%)
May 6, 2026, 3:00 PM CST
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 23.04 billion as of May 6, 2026. Its market cap has decreased by -27.62% in one year.
Market Cap
23.04B
Enterprise Value
22.14B
Revenue
3.82B
Ranking
n/a
PE Ratio
22.88
Stock Price
56.44
Market Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 23.04B, an increase of 60.43%. That is a compound annual growth rate of 7.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 23.78B | -30.39% |
| Dec 31, 2025 | 34.16B | 14.44% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai RAAS Blood Products | 36.46B |
| Chongqing Zhifei Biological Products | 36.27B |
| Beijing Tiantan Biological Products | 28.20B |
| Suzhou Zelgen Biopharmaceuticals | 27.53B |
| BrightGene Bio-Medical Technology | 26.66B |
| Hualan Biological Engineering | 26.35B |
| Yili Chuanning Biotechnology | 22.37B |
| Sinocelltech Group | 19.37B |